$39.12
0.05% yesterday
Nasdaq, Dec 23, 10:00 pm CET
ISIN
US03209R1032
Symbol
AMPH

Amphastar Pharmaceuticals Inc Stock price

$39.12
-5.52 12.37% 1M
-1.72 4.21% 6M
-22.73 36.75% YTD
-21.80 35.78% 1Y
+16.53 73.17% 3Y
+19.67 101.13% 5Y
+27.29 230.68% 10Y
Nasdaq, Closing price Mon, Dec 23 2024
-0.02 0.05%
ISIN
US03209R1032
Symbol
AMPH

Key metrics

Market capitalization $1.88b
Enterprise Value $2.26b
P/E (TTM) P/E ratio 13.02
EV/FCF (TTM) EV/FCF 13.27
EV/Sales (TTM) EV/Sales 3.12
P/S ratio (TTM) P/S ratio 2.60
P/B ratio (TTM) P/B ratio 2.60
Revenue growth (TTM) Revenue growth 20.33%
Revenue (TTM) Revenue $723.55m
EBIT (operating result TTM) EBIT $214.26m
Free Cash Flow (TTM) Free Cash Flow $170.15m
Cash position $252.93m
EPS (TTM) EPS $3.01
P/E forward 11.07
P/S forward 2.55
EV/Sales forward 3.06
Short interest 13.18%
Show more

Is Amphastar Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

Amphastar Pharmaceuticals Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Amphastar Pharmaceuticals Inc forecast:

4x Buy
67%
2x Hold
33%

Analyst Opinions

6 Analysts have issued a Amphastar Pharmaceuticals Inc forecast:

Buy
67%
Hold
33%

Financial data from Amphastar Pharmaceuticals Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
724 724
20% 20%
100%
- Direct Costs 352 352
25% 25%
49%
372 372
16% 16%
51%
- Selling and Administrative Expenses 37 37
7% 7%
5%
- Research and Development Expense 64 64
6% 6%
9%
271 271
24% 24%
37%
- Depreciation and Amortization 56 56
59% 59%
8%
EBIT (Operating Income) EBIT 214 214
17% 17%
30%
Net Profit 158 158
17% 17%
22%

In millions USD.

Don't miss a Thing! We will send you all news about Amphastar Pharmaceuticals Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Amphastar Pharmaceuticals Inc Stock News

Neutral
Accesswire
27 days ago
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 26, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the 36th Annual Piper Sandler Healthcare Conference on Wednesday, December 4th, 2024 at 11:30 am EST. For access, visit Amphastar's Pharmaceuticals websi...
Neutral
Investors Business Daily
about one month ago
The top five biotech stocks today have several commonalities. Among them are strong ratings.
Neutral
Accesswire
about one month ago
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 13, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 3:30 pm GMT. For access, visit Amphastar's Pharmaceuticals websi...
More Amphastar Pharmaceuticals Inc News

Company Profile

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Head office United States
CEO Yong Zhang
Employees 1,761
Founded 1996
Website www.amphastar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today